A COMBINATION STUDY OF KADCYLA (TRASTUZUMAB EMTANSINE) AND CAPECITABINE IN PARTICIPANTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE METASTATIC BREAST CANCER (MBC) OR HER2-POSITIVE LOCALLY ADVANCED/METASTATIC GASTRIC CANCER (LA/MGC):